These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 31480427)
1. Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials. Riemma G; Schiattarella A; La Verde M; Zarobbi G; Garzon S; Cucinella G; Calagna G; Labriola D; De Franciscis P Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480427 [No Abstract] [Full Text] [Related]
2. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause. Pinkerton JV; Joffe H; Kazempour K; Mekonnen H; Bhaskar S; Lippman J Menopause; 2015 Jan; 22(1):50-8. PubMed ID: 25137243 [TBL] [Abstract][Full Text] [Related]
3. Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis. Wei D; Chen Y; Wu C; Wu Q; Yao L; Wang Q; Wang XQ; Yang KH BJOG; 2016 Oct; 123(11):1735-43. PubMed ID: 27062457 [TBL] [Abstract][Full Text] [Related]
4. Phytoestrogens for menopausal vasomotor symptoms. Lethaby A; Marjoribanks J; Kronenberg F; Roberts H; Eden J; Brown J Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001395. PubMed ID: 24323914 [TBL] [Abstract][Full Text] [Related]
5. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial. Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589 [TBL] [Abstract][Full Text] [Related]
6. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Leach MJ; Moore V Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007244. PubMed ID: 22972105 [TBL] [Abstract][Full Text] [Related]
8. Paroxetine: a first for selective serotonin reuptake inhibitors - a new use: approved for vasomotor symptoms in postmenopausal women. Weber L; Thacker HL Womens Health (Lond); 2014 Mar; 10(2):147-54. PubMed ID: 24601805 [TBL] [Abstract][Full Text] [Related]
9. Bioidentical hormones for women with vasomotor symptoms. Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272 [TBL] [Abstract][Full Text] [Related]
10. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. Stearns V; Beebe KL; Iyengar M; Dube E JAMA; 2003 Jun; 289(21):2827-34. PubMed ID: 12783913 [TBL] [Abstract][Full Text] [Related]
11. Phytoestrogens for vasomotor menopausal symptoms. Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751 [TBL] [Abstract][Full Text] [Related]
12. Acupuncture for menopausal hot flushes. Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589 [TBL] [Abstract][Full Text] [Related]
13. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy. Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280 [TBL] [Abstract][Full Text] [Related]
14. Noradrenergic and serotonergic modulation to treat vasomotor symptoms. Albertazzi P J Br Menopause Soc; 2006 Mar; 12(1):7-11. PubMed ID: 16513016 [TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Portman DJ; Kaunitz AM; Kazempour K; Mekonnen H; Bhaskar S; Lippman J Menopause; 2014 Oct; 21(10):1082-90. PubMed ID: 24552977 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Clinical Meaningfulness of Red Clover ( Kanadys W; Barańska A; Błaszczuk A; Polz-Dacewicz M; Drop B; Kanecki K; Malm M Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920485 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis. Elnaga AAA; Alsaied MA; Elettreby AM; Ramadan A Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():142-152. PubMed ID: 38640780 [TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice. Ikeda M; Egawa T; Yamauchi A; Sohda Y; Koga A; Tominaga K; Shuto H; Kataoka Y Eur J Pharmacol; 2008 Jan; 579(1-3):439-44. PubMed ID: 18155696 [TBL] [Abstract][Full Text] [Related]
19. Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine. Simon JA; Chandler J; Gottesdiener K; Lazarus N; He W; Rosenberg E; Wagner JA; Denker AE Menopause; 2014 Sep; 21(9):938-44. PubMed ID: 24569618 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. Akhtar SMM; Ali A; Khan MS; Khan V; Fareed A; Saleem SZ; Mumtaz M; Ahsan MN; Iqbal S; Asghar MS Int J Gynaecol Obstet; 2024 Sep; 166(3):969-983. PubMed ID: 38563867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]